Diana Nuevo-Silva , Elena M. Garijo-Plano , Macarena Pariente-Martín , Juan J. Camarena-Miñana
{"title":"Human subcutaneous dirofilariasis: A case report","authors":"Diana Nuevo-Silva , Elena M. Garijo-Plano , Macarena Pariente-Martín , Juan J. Camarena-Miñana","doi":"10.1016/j.eimce.2025.02.008","DOIUrl":"10.1016/j.eimce.2025.02.008","url":null,"abstract":"","PeriodicalId":72916,"journal":{"name":"Enfermedades infecciosas y microbiologia clinica (English ed.)","volume":"43 7","pages":"Pages 452-453"},"PeriodicalIF":0.0,"publicationDate":"2025-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143560346","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Luis Fernando Lopez Cortes , Laura Amanda Vallejo Aparicio , Cristina Jimenez Navarro , Lucía Ruiz Moran
{"title":"In response to: “Cost analysis associated with intramuscular versus oral administration of antiretroviral therapy in the management of human immunodeficiency virus infection”","authors":"Luis Fernando Lopez Cortes , Laura Amanda Vallejo Aparicio , Cristina Jimenez Navarro , Lucía Ruiz Moran","doi":"10.1016/j.eimce.2025.06.006","DOIUrl":"10.1016/j.eimce.2025.06.006","url":null,"abstract":"","PeriodicalId":72916,"journal":{"name":"Enfermedades infecciosas y microbiologia clinica (English ed.)","volume":"43 7","pages":"Pages 456-457"},"PeriodicalIF":0.0,"publicationDate":"2025-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144531393","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Begoña Fachal Bugarín, Lucía Ramos Merino, Joaquín Manuel Serrano Arreba, Alicia Alonso Álvarez, Ramón María Fernández Varela, Berta Pernas Souto, Laura Gutiérrez Fernández, María Dolores Sousa Regueiro, Enrique Míguez Rey, Efrén Sánchez Vidal
{"title":"Listeria monocytogenes prosthetic joint infection: Two clinical cases and a review of the literature.","authors":"Begoña Fachal Bugarín, Lucía Ramos Merino, Joaquín Manuel Serrano Arreba, Alicia Alonso Álvarez, Ramón María Fernández Varela, Berta Pernas Souto, Laura Gutiérrez Fernández, María Dolores Sousa Regueiro, Enrique Míguez Rey, Efrén Sánchez Vidal","doi":"10.1016/j.eimce.2025.06.007","DOIUrl":"https://doi.org/10.1016/j.eimce.2025.06.007","url":null,"abstract":"<p><strong>Introduction: </strong>Most infections caused by Listeria monocytogenes occur in individuals with predisposing conditions, such as advanced age or the use of immunosuppressive therapies, and primarily manifest as bacteremia or meningoencephalitis. Osteoarticular infections are uncommon and typically affect joint prostheses, with late-onset infections following surgery. Treatment in these cases should include antibiotic therapy along with a surgical strategy, which generally involves the removal of the affected prosthesis.</p><p><strong>Methods: </strong>Two cases of prosthetic joint infection caused by L. monocytogenes are presented, along with a narrative review of the English and Spanish literature via PubMed up to December 2024.</p><p><strong>Results: </strong>To the best of our knowledge, 52 cases of prosthetic joint infection caused by L. monocytogenes have been reported since 2000. All patients had predisposing conditions, with advanced age being the most common (mean age of 71 years). Most cases were late infections following surgery. Combined treatment (antibiotic therapy and surgery) was used in two-thirds of cases. The prognosis was favorable in almost all instances.</p><p><strong>Discussion: </strong>It is important to consider L. monocytogenes in the etiological diagnosis of prosthetic joint infections, especially in elderly or immunocompromised patients. While the most used antibiotics have been ampicillin and cotrimoxazole, oxazolidinones could serve as an oral alternative for the treatment of these infections.</p>","PeriodicalId":72916,"journal":{"name":"Enfermedades infecciosas y microbiologia clinica (English ed.)","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2025-06-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144531394","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Francisco Javier Membrillo de Novales, Alfonso J Rodriguez-Morales, Adriana Sucari, Nancy Virginia Sandoval Paiz, Ivan Arturo Rodríguez Sabogal, Wendy Moncada Navas, Susana Lloveras, Gustavo Lopardo, Virgilio Lezcano, Alexis M Holguin, Inés Cerón, Rosa Abreu, Míriam J Álvarez-Martínez
{"title":"One year of the Latin American Alliance in Infectious Diseases and Clinical Microbiology: achievements and future challenges.","authors":"Francisco Javier Membrillo de Novales, Alfonso J Rodriguez-Morales, Adriana Sucari, Nancy Virginia Sandoval Paiz, Ivan Arturo Rodríguez Sabogal, Wendy Moncada Navas, Susana Lloveras, Gustavo Lopardo, Virgilio Lezcano, Alexis M Holguin, Inés Cerón, Rosa Abreu, Míriam J Álvarez-Martínez","doi":"10.1016/j.eimce.2025.06.002","DOIUrl":"https://doi.org/10.1016/j.eimce.2025.06.002","url":null,"abstract":"","PeriodicalId":72916,"journal":{"name":"Enfermedades infecciosas y microbiologia clinica (English ed.)","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2025-06-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144327966","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Esteban Sánchez-Toscano, Dunia Collazo-Yáñez, Jesús Domínguez-Riscart, Laura Larrán-Escandón, Andrés Martín-Aspas, Isabel Mateo-Gavira, Manuel Aguilar-Diosdado
{"title":"Screening for sexually transmitted infections in the transgender population and interaction of gender-affirming hormonal treatment with antiretroviral therapy.","authors":"Esteban Sánchez-Toscano, Dunia Collazo-Yáñez, Jesús Domínguez-Riscart, Laura Larrán-Escandón, Andrés Martín-Aspas, Isabel Mateo-Gavira, Manuel Aguilar-Diosdado","doi":"10.1016/j.eimce.2025.06.003","DOIUrl":"https://doi.org/10.1016/j.eimce.2025.06.003","url":null,"abstract":"<p><strong>Introduction: </strong>Current evidence suggests that transgender people have a higher risk of sexually transmitted infections (STIs) than general population, although most of the literature focuses on transwomen with HIV.</p><p><strong>Objective: </strong>To determine the prevalence of STDs diagnosed by serology in transgender population in our hospital and to analyze the impact of antiretroviral treatment on hormonal therapy.</p><p><strong>Methods: </strong>We design a cross-sectional study based on medical records of transgender people treated at the Transgender Care Unit of Cadiz from June 2022 to June 2023. Hepatitis, HIV and syphilis serology was requested from people between 16 and 65 years.</p><p><strong>Results: </strong>A total of 295 people were included, 48,14% transwomen (n = 142) and 51,86% transmen (n = 153), with an average age of 24,78 ± 9,2 years. It was detected 14 cases of HAV, 5 of syphilis, 3 of HBV and 3 of HCV. Prevalence of HIV was 3,73% (n = 11). Of the 9 transwomen with HIV infection, 3 of them required a change in antiretroviral medication and 2 cases required changes in the route of estrogen administration to achieve optimal plasma hormone levels.</p><p><strong>Conclusions: </strong>With the current model of care for transgender people in Andalusia, the prevalence of STDs detected in our sociocultural environment is low. Special attention should be paid to possible interactions between antiretroviral treatment and hormone therapy, especially in transwomen.</p>","PeriodicalId":72916,"journal":{"name":"Enfermedades infecciosas y microbiologia clinica (English ed.)","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2025-06-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144327968","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Marta Santos, Jesica Martín Carmona, Anais Corma-Gómez, Margarita Pérez-García, Carmen Martín-Sierra, Pilar Rincón-Mayo, Juan Antonio Pineda, Luis Miguel Real, Juan Macías
{"title":"Progression towards microelimination of hepatitis B virus infection among people living with HIV in Spain.","authors":"Marta Santos, Jesica Martín Carmona, Anais Corma-Gómez, Margarita Pérez-García, Carmen Martín-Sierra, Pilar Rincón-Mayo, Juan Antonio Pineda, Luis Miguel Real, Juan Macías","doi":"10.1016/j.eimce.2025.02.016","DOIUrl":"https://doi.org/10.1016/j.eimce.2025.02.016","url":null,"abstract":"<p><strong>Introduction: </strong>The WHO proposed to achieve hepatitis B virus (HBV) elimination by 2030, but this goal is very difficult to attain. People living with HIV (PLWH) may represent a subset where microelimination can be reached sooner. This study aimed to assess the incidence of HBV infections and changes in the prevalence of active HBV infection among PLWH in Spain.</p><p><strong>Methods: </strong>A prospective cohort study, including all PLWH attending a university hospital in Southern Spain from January 2011 to December 2022, was conducted. Serum HBV markers (HBsAg, anti-HBs, anti-HBc) were tested at baseline and at least yearly afterwards. Incident cases were identified by anti-HBc seroconversion.</p><p><strong>Results: </strong>Nine hundred and eighty PLWH were included. At the beginning of the study, 26 (2.7% [95% CI: 1.7-3.8%]) tested positive for HBsAg, 428 (43.7% [95% CI: 42.8-49.4%]) for anti-HBc and 386 (39.4% [95% CI: 39.8-46.3%]) for anti-HBs. After a median (Q1-Q3) follow-up of 115 (35-143) months, two new infections were documented, yielding an incidence rate of 2.24 (95% CI: 0.27-8.1)/100,000 person-years. The prevalence of active HBV infection declined from 3.4% [95% CI: 2.0-5.0%] in 2011 to 2% [95% CI: 1.0-3.0%] in 2022 (p for linear trend=0.027). At the end of the study, 167 (24%) PLWH still were susceptible to HBV.</p><p><strong>Conclusions: </strong>The incidence of HBV infection among PLWH in Spain is close to the WHO target. The prevalence of active HBV infection has decreased substantially during the last 12 years. These data suggest that micro-elimination of HBV/HIV infection is on the track in Spain.</p>","PeriodicalId":72916,"journal":{"name":"Enfermedades infecciosas y microbiologia clinica (English ed.)","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2025-06-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144227846","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Nuria Fernández Piñeiro , Oskar Ayerdi Aguirrebengoa , Eva Orviz García , Cristina González Pérez
{"title":"Reply to “How does PrEP work in the real life?”","authors":"Nuria Fernández Piñeiro , Oskar Ayerdi Aguirrebengoa , Eva Orviz García , Cristina González Pérez","doi":"10.1016/j.eimce.2025.03.015","DOIUrl":"10.1016/j.eimce.2025.03.015","url":null,"abstract":"","PeriodicalId":72916,"journal":{"name":"Enfermedades infecciosas y microbiologia clinica (English ed.)","volume":"43 6","pages":"Pages 369-370"},"PeriodicalIF":0.0,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144185382","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Javier Velasco Montes , María Victoria Pardo Gutiérrez , Carlos Hernando Martín , Silvia González Díez
{"title":"How does PrEP work in the real life?","authors":"Javier Velasco Montes , María Victoria Pardo Gutiérrez , Carlos Hernando Martín , Silvia González Díez","doi":"10.1016/j.eimce.2025.04.003","DOIUrl":"10.1016/j.eimce.2025.04.003","url":null,"abstract":"","PeriodicalId":72916,"journal":{"name":"Enfermedades infecciosas y microbiologia clinica (English ed.)","volume":"43 6","pages":"Page 369"},"PeriodicalIF":0.0,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144063314","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}